Geicu Lucian, Busuttil Olivier, D'Ostrevy Nicolas, Pernot Mathieu, Benali Walid, Labrousse Louis, Modine Thomas
Department of Cardiac Surgery, Montreal Heart Institute, Montreal University, Montreal, QC H1T 1C8, Canada.
Unité Médico-Chirurgicale, Hôpital Haut Lévêque, CHU de Bordeaux, CEDEX, 33604 Pessac, France.
J Clin Med. 2021 Oct 31;10(21):5140. doi: 10.3390/jcm10215140.
Over the last twenty years, we marked significant progresses in the field of tissue engineering and the development of new aortic valve structural and delivery systems. These continuous iterations on the field, have completely changed the surgical indications and approaches for AVR. Nowadays, therapeutic decisions are endorsed by international guidelines; however, new technical advances need a new integrated approach. The clinical scenarios issued from the interaction between the Guidelines and the newest approaches and technologies are regularly on debate by the Heart Team. We will present some of our most encountered situations and the pattern of our therapeutic decisions. To easily navigate through Guidelines and clinical scenarios, we reported in this review a simplified and easy to use Clinical decision-making algorithm that may be a valuable tool in our daily practice.
在过去二十年中，我们在组织工程领域以及新型主动脉瓣结构和输送系统的开发方面取得了重大进展。该领域的这些持续迭代彻底改变了主动脉瓣置换术（AVR）的手术适应症和方法。如今，治疗决策得到国际指南的认可；然而，新的技术进步需要一种新的综合方法。指南与最新方法和技术之间相互作用产生的临床情况经常成为心脏团队讨论的话题。我们将介绍一些我们最常遇到的情况以及我们的治疗决策模式。为了便于在指南和临床情况中进行导航，我们在本综述中报告了一种简化且易于使用的临床决策算法，它可能是我们日常实践中的一个有价值的工具。
